(Total Views: 369)
Posted On: 12/12/2019 12:55:22 PM
Post# of 148984
Not sure if we discussed the drug IMMU-132 before, but there is an article right now on Yahoo about "New Drugs Show Rare Promise Against Advanced Breast Cancer" put out on the Associated Press. Of course CYDY and Leronlimab are not mentioned, but someone posted the comment below and I wondered if we, as a group, were aware of this medication and the fact that it is "hopefully" up for approval and availability in 2020.
Link to article: https://www.yahoo.com/news/drugs-show-rare-pr...59100.html
Here is the comment: There's another drug that's close to FDA approval for TnBC (Triple Negative Breast Cancer) called IMMU-132. Immunomedic (IMMU) is the developer and hopefully this will soon be approved and available in 2020. Keep a close eye this one as results have been very good so far and with very good safety profile and minimal side effects. Fingers crossed.
Link to article: https://www.yahoo.com/news/drugs-show-rare-pr...59100.html
Here is the comment: There's another drug that's close to FDA approval for TnBC (Triple Negative Breast Cancer) called IMMU-132. Immunomedic (IMMU) is the developer and hopefully this will soon be approved and available in 2020. Keep a close eye this one as results have been very good so far and with very good safety profile and minimal side effects. Fingers crossed.
(0)
(0)Scroll down for more posts ▼
